What is GelStat Corp?
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.
GSAC · Verdict
Moderate reward · high risk
GSAC has limited near-term tailwinds — volatility and balance sheet weigh on the model output.
Based on 88% data coverage
GSAC · Verdict
Weak vs peers
Current ratio 0.07
-16% free-cash-flow margin
-107% net margin · -27% ROE
Model-based scoring. For information only — not financial advice.
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company is listed on the PINK in USA, operating in the Technology sector, with a market capitalisation of 510.19K.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.